Clinical Trial Update: Huperzine-A to Help With Mental Problems and the Inability to Care for Onself in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating huperzine-A for cognitive and functional impairments in patients with schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia
• Schizophrenia

Drugs mentioned

• Huperzine A (Huperzine A)

Snippet

Sponsor: VA Nebraska Western Iowa Health Care System | Conditions: Schizophrenia, Dementia | Phase 4 | Status: UNKNOWN